| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,150,762 | 4,016,638 | 3,715,592 | 3,673,874 | | Cost of Revenue | 1,467,507 | 1,790,954 | 1,656,872 | 1,645,304 | | | Gross Profit | 1,683,255 | 2,225,684 | 2,058,720 | 2,028,570 | | | Operating Expenses | | Research Development | 383,293 | 434,521 | 410,793 | 442,502 | | Selling General and Administrative | 1,024,773 | 1,211,120 | 1,172,579 | 1,135,674 | | Non Recurring | 15,572 | 247,270 | 4,398 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 259,617 | 332,773 | 470,950 | 450,394 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29,086 | 35,944 | 43,404 | 55,919 | | Earnings Before Interest And Taxes | 288,703 | 368,717 | 514,354 | 506,313 | | Interest Expense | 45,543 | 18,446 | 18,492 | 18,794 | | Income Before Tax | 243,160 | 350,271 | 495,862 | 487,519 | | Income Tax Expense | 37,815 | 44,569 | 71,452 | 102,338 | | Minority Interest |
-
| (17,718) | (13,133) | (7,713) | | | | Net Income From Continuing Ops | 205,345 | 287,984 | 411,277 | 377,468 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 205,345 | 287,984 | 411,277 | 377,468 | | Preferred Stock And Other Adjustments | (11,276) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $194,069 | $287,984 | $411,277 | $377,468 |
|
0.45% Nasdaq 
0.20%
Income Statement
